ClinicalTrials.gg

Agomab Spain S.L.U. clinical trials

Acquired by Agomab Therapeutics NV, Dec 14, 2021 · source ↗

The registry lists 5 studies whose lead sponsor is Agomab Spain S.L.U. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 19, 2026.

Before and after it joined Agomab Therapeutics NV

First submitted before Agomab Spain S.L.U. became part of Agomab Therapeutics NV
0
First submitted after Agomab Spain S.L.U. became part of Agomab Therapeutics NV
5
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Agomab Spain S.L.U.’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Agomab Spain S.L.U.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. 1J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 5 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now360%Recruiting 2 · Not yet recruiting 1
  • Completed240%

Phase

  • Phase 23
  • Phase 12

Where

  • United Kingdom2
  • United States2
  • Spain1
  • Belgium1
  • Italy1
  • Germany1

Over the years

  1. 23
  2. 24
  3. 25
  4. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Agomab Spain S.L.U.5 studies

Something wrong with this grouping? Tell us on the Agomab Therapeutics NV page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All Agomab Therapeutics NV studies →